TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,273,314
|
1,133,610
|
2,351,227 |
| Earnings before taxes |
48,602
|
65,279
|
53,544 |
| Total assets |
547,056
|
532,463
|
1,166,287 |
| Current assets |
527,032
|
509,040
|
561,967 |
| Current liabilities |
286,630
|
322,299
|
325,945 |
| Equity capital |
252,303
|
207,813
|
731,991 |
| - share capital |
6,159
|
5,955
|
5,986 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.1%
|
39.0%
|
62.8% |
| Turnover per employee |
8,489
|
7,557
|
15,675 |
| Profit as a percentage of turnover |
3.8%
|
5.8%
|
2.3% |
| Return on assets (ROA) | |||
| Current ratio |
183.9%
|
157.9%
|
172.4% |
| Return on equity (ROE) |
19.3%
|
31.4%
|
7.3% |
| Change turnover |
100,926
|
-1,205,571
|
1,254,556 |
| Change turnover % |
9%
|
-52%
|
114% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.